Finance

Lists
Why is GALT down 4.07%?
Dive Deeper
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.88
-4.07%
(-0.17) 1D
Sep 24, 11:06:48 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GALT...
Open
$4.00
High
$4.04
Low
$3.86
Mkt. cap
391.80M
Avg. vol.
338.60K
Volume
27.97K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.38
Shares outstanding
100.85M
No. of employees
9
Open
$4.00
High
$4.04
Low
$3.86
Mkt. cap
391.80M
Avg. vol.
338.60K
Volume
27.97K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.38
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorBiotechnology
Websitegalectintherapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to GALT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GALT in the last 3 months
Highest
Current $3.88
$11.00 (+183.14%)
Average
$11.00 (+183.14%)
Lowest
$11.00 (+183.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$11.00
+183.1%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.61M
1.93M
2.23M
2.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59M
1.43M
1.85M
1.85M
Operating expense
4.20M
3.36M
4.08M
3.98M
Total operating expenses
4.20M
3.36M
4.08M
3.98M
Operating income
-4.20M
-3.36M
-4.08M
-3.98M
Other non operating income
-2.20M
-221.00K
983.00K
-3.16M
EBT including unusual items
-8.18M
-5.50M
-5.05M
-9.11M
EBT excluding unusual items
-8.18M
-5.50M
-5.05M
-9.11M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.18M
-5.50M
-5.05M
-9.11M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
39.00K
25.00K
36.00K
28.00K
Interest expense
-1.82M
-1.94M
-1.99M
-2.00M
Net interest expenses
-1.78M
-1.91M
-1.95M
-1.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps